Prudential Financial’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.13M | Buy |
182,873
+22,400
| +14% | +$498K | 0.01% | 1007 |
|
|
2025
Q4 | $4.15M | Buy |
160,473
+11,025
| +7% | +$262K | 0.01% | 1000 |
|
|
2025
Q3 | $3.85M | Buy |
149,448
+72,720
| +95% | +$1.79M | ﹤0.01% | 1062 |
|
|
2025
Q2 | $1.83M | Buy |
76,728
+2,500
| +3% | +$63K | ﹤0.01% | 1424 |
|
|
2025
Q1 | $1.84M | Sell |
74,228
-179,940
| -71% | -$4.31M | ﹤0.01% | 1318 |
|
|
2024
Q4 | $4.79M | Sell |
254,168
-190,286
| -43% | -$3.34M | 0.01% | 892 |
|
|
2024
Q3 | $6.69M | Buy |
444,454
+237,629
| +115% | +$4.06M | 0.01% | 856 |
|
|
2024
Q2 | $5.92M | Buy |
206,825
+124,951
| +153% | +$3.56M | 0.01% | 858 |
|
|
2024
Q1 | $2.39M | Buy |
81,874
+22,269
| +37% | +$684K | ﹤0.01% | 1344 |
|
|
2023
Q4 | $2.01M | Buy |
59,605
+4,529
| +8% | +$133K | ﹤0.01% | 1433 |
|
|
2023
Q3 | $1.69M | Sell |
55,076
-2,423
| -4% | -$87.3K | ﹤0.01% | 1468 |
|
|
2023
Q2 | $2.3M | Buy |
57,499
+12,055
| +27% | +$498K | ﹤0.01% | 1321 |
|
|
2023
Q1 | $1.85M | Sell |
45,444
-1,152
| -2% | -$45.8K | ﹤0.01% | 1387 |
|
|
2022
Q4 | $1.8M | Sell |
46,596
-2,250
| -5% | -$109K | ﹤0.01% | 1376 |
|
|
2022
Q3 | $2.65M | Buy |
48,846
+92
| +0.2% | +$5.12K | ﹤0.01% | 1163 |
|
|
2022
Q2 | $2.86M | Sell |
48,754
-83
| -0.2% | -$5.44K | ﹤0.01% | 1192 |
|
|
2022
Q1 | $3.73M | Sell |
48,837
-466
| -0.9% | -$31.1K | 0.01% | 1138 |
|
|
2021
Q4 | $2.78M | Buy |
49,303
+1,119
| +2% | +$61.7K | ﹤0.01% | 1352 |
|
|
2021
Q3 | $2.7M | Sell |
48,184
-327
| -0.7% | -$18.8K | ﹤0.01% | 1308 |
|
|
2021
Q2 | $2.94M | Sell |
48,511
-2,561
| -5% | -$162K | ﹤0.01% | 1293 |
|
|
2021
Q1 | $3.58M | Buy |
51,072
+676
| +1% | +$48.3K | 0.01% | 1171 |
|
|
2020
Q4 | $3.02M | Buy |
50,396
+49
| +0.1% | +$2.87K | 0.01% | 1227 |
|
|
2020
Q3 | $3.03M | Sell |
50,347
-110,720
| -69% | -$6.43M | 0.01% | 1120 |
|
|
2020
Q2 | $8.45M | Buy |
161,067
+13,030
| +9% | +$545K | 0.02% | 759 |
|
|
2020
Q1 | $4.96M | Sell |
148,037
-6,638
| -4% | -$276K | 0.01% | 920 |
|
|
2019
Q4 | $7.01M | Buy |
154,675
+3,951
| +3% | +$168K | 0.01% | 988 |
|
|
2019
Q3 | $5.74M | Buy |
150,724
+145,792
| +2,956% | +$5.82M | 0.01% | 1051 |
|
|
2019
Q2 | $214K | Sell |
4,932
-65,577
| -93% | -$2.78M | ﹤0.01% | 2320 |
|
|
2019
Q1 | $2.68M | Sell |
70,509
-3,280
| -4% | -$128K | ﹤0.01% | 1448 |
|
|
2018
Q4 | $3.17M | Sell |
73,789
-4,495
| -6% | -$210K | 0.01% | 1286 |
|
|
2018
Q3 | $3.85M | Buy |
+78,284
| New | +$3.38M | 0.01% | 1296 |
|
|
2016
Q2 | – | Sell |
-13,376
| Closed | -$709K | – | 2318 |
|
|
2016
Q1 | $709K | Buy |
13,376
+9,631
| +257% | +$563K | ﹤0.01% | 1922 |
|
|
2015
Q4 | $288K | Buy |
+3,745
| New | +$212K | ﹤0.01% | 2079 |
|
|
2015
Q3 | – | Sell |
-3,745
| Closed | -$265K | – | 2251 |
|
|
2015
Q2 | $265K | Hold |
3,745
| – | – | ﹤0.01% | 2080 |
|
|
2015
Q1 | $333K | Sell |
3,745
-200
| -5% | -$20.3K | ﹤0.01% | 2057 |
|
|
2014
Q4 | $350K | Hold |
3,945
| – | – | ﹤0.01% | 2002 |
|
|
2014
Q3 | $382K | Sell |
3,945
-3,545
| -47% | -$345K | ﹤0.01% | 1976 |
|
|
2014
Q2 | $688K | Buy |
7,490
+4,075
| +119% | +$310K | ﹤0.01% | 1928 |
|
|
2014
Q1 | $239K | Buy |
+3,415
| New | +$232K | ﹤0.01% | 2120 |
|
Other funds holding PCRX
DPCM
VPM
VCM
